UNLABELLED: OBJECTIVES AND WORKING HYPOTHESIS: To evaluate the prevalence of respiratory viruses Mycoplasma pneumoniae and Chlamydophila pneumoniae and gain insight into their seasonal circulation pattern in children with acute asthma exacerbations in a temperate southern hemisphere region. STUDY DESIGN: Patients hospitalized between 3 months and 16 years of age were included in a 1-year prospective, observational, cross-sectional study. Respiratory secretions were collected and the presence of different viruses and atypical bacteria analyzed by immunofluorescence and polymerase chain reaction. RESULTS: Two hundred nine patients (118 females) aged (mean +/- SD) 4.4 +/- 4 years were included. A potential causative agent was detected in 78% of the patients. The most frequently detected viruses were respiratory syncytial virus (HRSV) (n = 85; 40%) and rhinovirus (HRV) (n = 52; 24.5%); M. pneumoniae and C. pneumoniae were detected in 4.5% and 2% of the cases, respectively. Patients with HRSV (vs. HRV) were hospitalized for a longer time (6.7 vs. 5.2 days, P = 0.012), required more days of oxygen supply (5.1 vs. 3.4, P = 0.005), had a longer duration of the exacerbation before hospitalization (3.6 vs. 1.9 days, P = 0.001) and were younger (3.7 vs. 5.1 years, P = 0.012). Three peaks of admissions were observed. A first peak (early autumn) caused by HRV, a second peak (winter) caused mainly by HRSV and a third one (spring), caused by HRSV, an increase in HMPV together with a second outbreak of HRV. CONCLUSIONS: Children with an acute asthma exacerbation presented a high prevalence of respiratory viruses. Most hospitalizations corresponded to seasonal increases in prevalence of HRV and HRSV.
UNLABELLED: OBJECTIVES AND WORKING HYPOTHESIS: To evaluate the prevalence of respiratory viruses Mycoplasma pneumoniae and Chlamydophila pneumoniae and gain insight into their seasonal circulation pattern in children with acute asthma exacerbations in a temperate southern hemisphere region. STUDY DESIGN:Patients hospitalized between 3 months and 16 years of age were included in a 1-year prospective, observational, cross-sectional study. Respiratory secretions were collected and the presence of different viruses and atypical bacteria analyzed by immunofluorescence and polymerase chain reaction. RESULTS: Two hundred nine patients (118 females) aged (mean +/- SD) 4.4 +/- 4 years were included. A potential causative agent was detected in 78% of the patients. The most frequently detected viruses were respiratory syncytial virus (HRSV) (n = 85; 40%) and rhinovirus (HRV) (n = 52; 24.5%); M. pneumoniae and C. pneumoniae were detected in 4.5% and 2% of the cases, respectively. Patients with HRSV (vs. HRV) were hospitalized for a longer time (6.7 vs. 5.2 days, P = 0.012), required more days of oxygen supply (5.1 vs. 3.4, P = 0.005), had a longer duration of the exacerbation before hospitalization (3.6 vs. 1.9 days, P = 0.001) and were younger (3.7 vs. 5.1 years, P = 0.012). Three peaks of admissions were observed. A first peak (early autumn) caused by HRV, a second peak (winter) caused mainly by HRSV and a third one (spring), caused by HRSV, an increase in HMPV together with a second outbreak of HRV. CONCLUSIONS:Children with an acute asthma exacerbation presented a high prevalence of respiratory viruses. Most hospitalizations corresponded to seasonal increases in prevalence of HRV and HRSV.
Authors: Sebastian L Johnston; Francesco Blasi; Peter N Black; Richard J Martin; David J Farrell; Richard B Nieman Journal: N Engl J Med Date: 2006-04-13 Impact factor: 91.245
Authors: Peter D Sly; Attilio L Boner; Bengt Björksten; Andy Bush; Adnan Custovic; Philippe A Eigenmann; James E Gern; Jorrit Gerritsen; Eckard Hamelmann; Peter J Helms; Robert F Lemanske; Fernando Martinez; Soren Pedersen; Harald Renz; Hugh Sampson; Erika von Mutius; Ulrich Wahn; Patrick G Holt Journal: Lancet Date: 2008-09-20 Impact factor: 79.321
Authors: S L Johnston; P K Pattemore; G Sanderson; S Smith; F Lampe; L Josephs; P Symington; S O'Toole; S H Myint; D A Tyrrell Journal: BMJ Date: 1995-05-13
Authors: F Freymuth; A Vabret; J Brouard; F Toutain; R Verdon; J Petitjean; S Gouarin; J F Duhamel; B Guillois Journal: J Clin Virol Date: 1999-08 Impact factor: 3.168
Authors: Pasi Lehtinen; Aino Ruohola; Timo Vanto; Tytti Vuorinen; Olli Ruuskanen; Tuomas Jartti Journal: J Allergy Clin Immunol Date: 2006-12-27 Impact factor: 10.793
Authors: Tuomas Jartti; Pasi Lehtinen; Tytti Vuorinen; Riika Osterback; Bernadette van den Hoogen; Albert D M E Osterhaus; Olli Ruuskanen Journal: Emerg Infect Dis Date: 2004-06 Impact factor: 6.883
Authors: Pamela R Wood; Vanessa L Hill; Margaret L Burks; Jay I Peters; Harjinder Singh; Thirumalai R Kannan; Shruthi Vale; Marianna P Cagle; Molly F R Principe; Joel B Baseman; Edward G Brooks Journal: Ann Allergy Asthma Immunol Date: 2013-02-23 Impact factor: 6.347
Authors: Pradeep Reddy Marri; Debra A Stern; Anne L Wright; Dean Billheimer; Fernando D Martinez Journal: J Allergy Clin Immunol Date: 2012-12-23 Impact factor: 10.793
Authors: Adam M Collison; Leon A Sokulsky; Elizabeth Kepreotes; Ana Pereira de Siqueira; Matthew Morten; Michael R Edwards; Ross P Walton; Nathan W Bartlett; Ming Yang; Thi Hiep Nguyen; Sebastian L Johnston; Paul S Foster; Joerg Mattes Journal: JCI Insight Date: 2021-04-08
Authors: Guido Lopes Dos Santos Santiago; Guy Brusselle; Kenny Dauwe; Pieter Deschaght; Chris Verhofstede; Dries Vaneechoutte; Ellen Deschepper; Paul Jordens; Guy Joos; Mario Vaneechoutte Journal: BMC Microbiol Date: 2017-05-10 Impact factor: 3.605
Authors: Ahmed R Alsuwaidi; Alia M Alkalbani; Afaf Alblooshi; Junu George; Ghaya Albadi; Salwa M Kamal; Hassib Narchi; Abdul-Kader Souid Journal: J Asthma Allergy Date: 2018-09-12